Prazitone
Systematic (IUPAC) name | |
---|---|
5-phenyl-5-(piperidin-2-ylmethyl)pyrimidine-2,4,6(1H,3H,5H)-trione | |
Clinical data | |
Identifiers | |
2409-26-9 | |
None | |
PubChem | CID 3050417 |
ChemSpider | 2312482 |
UNII | 6DZB018428 |
Synonyms | 5-phenyl-5-(2-piperidylmethyl)barbituric acid |
Chemical data | |
Formula | C16H19N3O3 |
301.34 g/mol | |
SMILES
| |
| |
(what is this?) (verify) |
Prazitone (AGN-511) is a barbiturate derivative developed in the 1970s.[1] Unlike most barbiturates, it has little or no sedative effects, instead acting as a non-sedating anxiolytic and antidepressant.[2] The dosage range in humans is around 200–600 mg, although higher doses have been used in trials for the treatment of depression associated with Parkinson's disease.
References
|
|